Completed

Chest Wall Muscle Stretching and Acute Effects on Volume Variation of Thoracoabdominal Wall and Electromyographic Activity in Chronic Obstructive Pulmonary Disease

0 criteria met from your profileSee at a glance how your profile meets each eligibility criteria.
What is being tested

Stretching

Procedure
Who is being recruted

Chronic Disease+5

+ Lung Diseases

+ Lung Diseases, Obstructive

Over 40 Years
+14 Eligibility Criteria
See all eligibility criteria
How is the trial designed

Treatment Study

Interventional
Study Start: May 2011
See protocol details

Summary

Principal SponsorUniversidade Federal de Pernambuco
Last updated: April 8, 2013
Sourced from a government-validated database.Claim as a partner

Study start date: May 1, 2011

Actual date on which the first participant was enrolled.

Randomized controlled trial involving patients with Chronic Obstructive Pulmonary Disease evaluated before and immediately after a program of stretching muscles of the rib cage or after resting with time similar to the intervention, as volume variation of thoracoabdominal wall by optoelectronic plethysmography and on the electromyographic activity of accessory muscles of respiration.

Principal SponsorUniversidade Federal de Pernambuco
Last updated: April 8, 2013
Sourced from a government-validated database.Claim as a partner

Protocol

This section provides details of the study plan, including how the study is designed and what the study is measuring.
Design Details

28 patients to be enrolled

Total number of participants that the clinical trial aims to recruit.

Treatment Study

These studies test new ways to treat a disease, condition, or health issue. The goal is to see if a new drug, therapy, or approach works better or has fewer side effects than existing options.



Eligibility

Researchers look for people who fit a certain description, called eligibility criteria: person's general health condition or prior treatments.
Conditions
Criteria

Any sex

Biological sex of participants that are eligible to enroll.

Over 40 Years

Range of ages for which participants are eligible to join.

Healthy volunteers not allowed

If individuals who are healthy and do not have the condition being studied can participate.

Conditions

Pathology

Chronic DiseaseLung DiseasesLung Diseases, ObstructivePathologic ProcessesRespiratory Tract DiseasesPathological Conditions, Signs and SymptomsDisease AttributesPulmonary Disease, Chronic Obstructive

Criteria

10 inclusion criteria required to participate
age above 40 years

body mass index (BMI) between 18.5 and 29.9 kg / m^2

both sexes

clinical and functional diagnosis of Chronic obstructive pulmonary disease according to the Global Initiative for Chronic Obstructive Lung Disease (GOLD, 2009)

Show More Criteria

4 exclusion criteria prevent from participating
Disease exacerbation for at least eight weeks

cardiovascular or osteoarticular and

participants in pulmonary rehabilitation programs

patients with other respiratory diseases

Study Plan

Find out more about all the medication administered in this study, their detailed description and what they involve.
Treatment Groups
Study Objectives

2 intervention groups are designated in this study

This study does not include a placebo group 

Treatment Groups

Group I

Active Comparator
The respiratory muscle stretching were developed bilaterally as follows: Upper trapezius: head lateral flexion with a hand therapist supports the the occipital region and his shoulder, promotes the stretching; Sternocleidomastoid: was stretched with flexion lateral and rotation of the head to the side which hands on the occipital region and in the sternal region; Scalene: with one hand on the occipital region and the other in the sternum, the two points was stretched; Pectoralis major: the arm was abducted, flexed the forearm and hand was in the occipital region the therapist hands in the arm and in the side of the upper chest, which was stretched craniocaudal direction; Intercostal: therapist performs with both hands to mobilize and stretch the ribs in cranial-caudal directions.

Group II

No Intervention
COPD patients were not submitted to any intervention, remaining at rest in the same place, position and time period to the treatment group.

Study Objectives

Primary Objectives

Secondary Objectives

Study Centers

These are the hospitals, clinics, or research facilities where the trial is being conducted. You can find the location closest to you and its status.

This study has 1 location

UFPE

Recife, BrazilOpen UFPE in Google Maps
CompletedOne Study Center